alpha-acetoxy-N-nitrosopyrrolidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 107766 |
| SCHEMBL ID | 10412809 |
| MeSH ID | M0111495 |
| Synonym |
|---|
| n-nitroso-(alpha-acetoxy)pyrrolidine |
| alpha-acetoxy-n-nitrosopyrrolidine |
| 2-pyrrolidinol, 1-nitroso-, acetate (ester) |
| 1-nitroso-2-pyrrolidinol acetate (ester) |
| alpha-acetoxynitrosopyrrolidine |
| brn 1527046 |
| 1-nitrosopyrrolidin-2-yl acetate |
| 59435-85-7 |
| (1-nitrosopyrrolidin-2-yl) acetate |
| AKOS006279848 |
| 5-21-01-00012 (beilstein handbook reference) |
| SCHEMBL10412809 |
| a-acetoxy-n-nitrosopyrrolidine |
| DTXSID90974842 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.84) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||